CliffBio
small molecule

SEYSARA

SARECYCLINE HYDROCHLORIDE

Loss of exclusivityFebruary 2033latest FDA-listed patent expiry
CompanyAlmirall →View the full company profile on CliffBio

Drug detail

Brand nameSEYSARA
Active ingredientSARECYCLINE HYDROCHLORIDE
StrengthEQ 150MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2018
Marketing statusRX

Listed patents

PatentExpiresType
9255068February 2033substance, product
8318706January 2032substance, product
8513223December 2029use U-2406
9481639August 2028use U-2409

More from Almirall

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

SEYSARA patent cliff — loss of exclusivity February 2033 | CliffBio